Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Poignard

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Journal of Virology|September 13, 2003
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodiesJohn R Mascola, Mark G Lewis, Thomas C VanCott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
Anti-HIV B Cell lines as candidate vaccine biosensorsTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
The Journal of Experimental Medicine|August 23, 2017
Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodiesIrene Sanjuan Nandin, Carol Fong, Cecilia Deantonio, et al.
Scientific Reports|September 24, 2021
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort studyAntonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
The Journal of Experimental Medicine|July 26, 2017
Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodiesIrene Sanjuan Nandin, Carol Fong, Cecilia Deantonio, et al.
Journal of Virology|March 8, 2013
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopesSimon Hoffenberg, Rebecca Powell, Alexei Carpov, et al.
Immunity|April 29, 2014
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimersClaudia Blattner, Jeong Hyun Lee, Kwinten Sliepen, et al.
Scientific Reports|July 23, 2021
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort studyAntonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Immunity|July 18, 2019
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-GlycanJeffrey Umotoy, Bernard S Bagaya, Collin Joyce, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Journal of Virology|September 13, 2003
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodiesJohn R Mascola, Mark G Lewis, Thomas C VanCott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
Anti-HIV B Cell lines as candidate vaccine biosensorsTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
The Journal of Experimental Medicine|August 23, 2017
Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodiesIrene Sanjuan Nandin, Carol Fong, Cecilia Deantonio, et al.
Scientific Reports|September 24, 2021
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort studyAntonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
The Journal of Experimental Medicine|July 26, 2017
Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodiesIrene Sanjuan Nandin, Carol Fong, Cecilia Deantonio, et al.
Journal of Virology|March 8, 2013
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopesSimon Hoffenberg, Rebecca Powell, Alexei Carpov, et al.
Immunity|April 29, 2014
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimersClaudia Blattner, Jeong Hyun Lee, Kwinten Sliepen, et al.
Scientific Reports|July 23, 2021
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort studyAntonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Immunity|July 18, 2019
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-GlycanJeffrey Umotoy, Bernard S Bagaya, Collin Joyce, et al.
Pageof 9